CN102600049B - Medical unhairing spray and purpose of medical unhairing spray - Google Patents
Medical unhairing spray and purpose of medical unhairing spray Download PDFInfo
- Publication number
- CN102600049B CN102600049B CN201210076954.1A CN201210076954A CN102600049B CN 102600049 B CN102600049 B CN 102600049B CN 201210076954 A CN201210076954 A CN 201210076954A CN 102600049 B CN102600049 B CN 102600049B
- Authority
- CN
- China
- Prior art keywords
- phase
- spray
- medical
- depilation
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007921 spray Substances 0.000 title claims abstract description 25
- 230000035617 depilation Effects 0.000 claims description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 12
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 12
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 claims description 12
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 7
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 6
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 6
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 6
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 6
- 229940036350 bisabolol Drugs 0.000 claims description 6
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 6
- CNYFJCCVJNARLE-UHFFFAOYSA-L calcium;2-sulfanylacetic acid;2-sulfidoacetate Chemical compound [Ca+2].[O-]C(=O)CS.[O-]C(=O)CS CNYFJCCVJNARLE-UHFFFAOYSA-L 0.000 claims description 6
- 230000036571 hydration Effects 0.000 claims description 6
- 238000006703 hydration reaction Methods 0.000 claims description 6
- 239000001282 iso-butane Substances 0.000 claims description 6
- 235000013847 iso-butane Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 6
- 229960003500 triclosan Drugs 0.000 claims description 6
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 5
- 239000000920 calcium hydroxide Substances 0.000 claims description 5
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000004411 aluminium Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract 4
- 210000003491 skin Anatomy 0.000 description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 239000003380 propellant Substances 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 241001116389 Aloe Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 235000011399 aloe vera Nutrition 0.000 description 3
- 239000003124 biologic agent Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 239000013043 chemical agent Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 206010067268 Post procedural infection Diseases 0.000 description 2
- 208000031650 Surgical Wound Infection Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010036410 Postoperative wound infection Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 150000003863 ammonium salts Chemical group 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- -1 polysiloxanes Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medical unhairing spray. Through the medical unhairing spray provided by the invention, the existing and traditional skin preservation technology and products can be replaced, the unconventional traditional skin preservation can be fast, efficiently, safely and conveniently carried on operation receivers, the sterilization and the skin preservation succeed in one step, the infection rate of the skin preservation parts and the operation cuts is greatly reduced, and meanwhile, the operation risk is also reduced.
Description
Technical field:
The present invention relates to medical depilation spray, belong to medicine, medical instruments field.
Background technology:
Preserved skin is exactly that the skin of operative region is carried out to chaeta removal, clean, sterilization, to guarantee to perform the operation, carries out smoothly and reduce postoperative infection.(because of a large amount of antibacterials in skin, hair, understand contamination of incision, cause postoperative infection, hair is not removed also can cause otch internal memory foreign body, cause infection of incisional wound, disunion).Preserved skin method can be divided into conventional traditional preserved skin and unconventional traditional preserved skin, and at present, what China adopted is conventional traditional razor preserved skin method, and its shortcoming is a lot, but because of without preserved skin substitute technology and product, so use till today always.
The shortcoming of conventional traditional preserved skin method:
1, razor preserved skin can cause skin histology damage, the visible trickle wound of skin histology, hyperemia, ooze out, redness, patient's pain is felt bad, but also can cause the infection of preserved skin position and operative incision, the infection rate of conventional traditional preserved skin is 5.6%, has greatly increased the risk of operation.
2, razor preserved skin complicated operation, time-consuming, take a lot of work, require great effort, particularly skinfold place has destroyed skin barrier, skin injury, wound infection rate is high; Department of obstetrics and gynecology, urology department, oxter preserved skin operate difficult.
According to < < Guideline For Prevention of Surgical Wound Infections > > (prevention of surgical wound infection guide) and U.S. peri-operation period registered nurse association (AORN) research report of the Center for Disease Control CDC, using the infection rate of the SSI of razor preserved skin is 5.6%, and use the SSI infection rate of depilatory preserved skin, be only 0.6%, so, Dispoable medical depilation spray preserved skin can reduce the infection rate of operative site greatly, also be unique method and the approach that reduces NIR.
Summary of the invention:
One aspect of the present invention relates to a kind of medical depilation spray, it is characterized in that the composition that contains following weight proportioning:
1. medical depilation spray, is characterized in that the composition that contains following weight proportioning: (%) formula: (%)
A phase (oil phase) B phase (water)
High viscosity white oil 2.0-5.0 carbamide 5.0-10.0
Silicone oil 1.0-4.0 sodium pyrosulfite 0.2-0.4
Emulsifying agent 4.0-8.0 60% potassium hydroxide solution 3.0-7.0
16-18 alcohol 4.0-8.0 carbomer Carbopol 934 0.1-0.3
Stearic acid 1.0-3.0 glycerol 3.0-7.0
Essence 0-0.4 propylene glycol 3.0-7.0
Methyl p-hydroxybenzoate 0.1-0.3 deionized water adds to 100
Ethyl hydroxybenzoate 0.5-1.0
C phase (chemical agent phase) D phase (biological agent phase)
Three hydration calcium mercaptoacetate 6.0-15.0 triclosan or quaternary ammonium salt 0.1-3
Calcium hydroxide 0.8-1.5 neutral red bisabolol 0.2-0.4
E phase (plant extract phase/skin protection phase)
Mentholum 0.1-0.3
Vitamin E 0.5-1.5
Aloe extraction solution 3.0-7.0
F phase (propellant)
Normal butane, iso-butane and/or n-propane 7-10 or Compressed Gas (nitrogen) 10-30 or dimethyl ether 20-25 or fluoric ether 7-15
In a preferred embodiment of the present invention, described emulsifying agent is A25.
In a preferred embodiment of the present invention, described depilatory agent is three hydration calcium mercaptoacetates.
In a preferred embodiment of the present invention, described propellant is normal butane, iso-butane and/or n-propane 7-10 or Compressed Gas (nitrogen) 10-30 or dimethyl ether 20-25 or fluoric ether 7-15.
In a preferred embodiment of the present invention, antibacterial is triclosan and quaternary ammonium salt derivative, complex (polyquaternary ammonium salt, organosilicon quaternary ammonium salt, bi-quaternary ammonium salt polysiloxanes 0.1% one 3%).
In a preferred embodiment of the present invention, anti-sensitizer is neutral red bisabolol 0.2%-0.4%.
In a preferred embodiment of the present invention, described medical depilation spray, is characterized in that the composition that contains following weight proportioning: (%)
A phase (oil phase) B phase (water)
High viscosity white oil 2.0-5.0 carbamide 5.0-10.0
Silicone oil 1.0-4.0 sodium pyrosulfite 0.2-0.4
Emulsifying agent 4.0-8.0 60% potassium hydroxide solution 3.0-7.0
16-18 alcohol 4.0-8.0 carbomer Carbopol 934 0.1-0.3
Stearic acid 1.0-3.0 glycerol 3.0-7.0
Essence 0-0.4 propylene glycol 3.0-7.0
Methyl p-hydroxybenzoate 0.1-0.3 deionized water adds to 100
Ethyl hydroxybenzoate 0.5-1.0
C phase (chemical agent phase) D phase (biological agent phase)
Three hydration calcium mercaptoacetate 6.0-15.0 triclosan or quaternary ammonium salt 0.1-3
Calcium hydroxide 0.8-1.5 neutral red bisabolol 0.2-0.4
E phase (plant extract phase/skin protection phase)
Mentholum 0.1-0.3
Vitamin E 0.5-1.5
Aloe extraction solution 3.0-7.0
F phase (propellant)
Normal butane, iso-butane and/or n-propane 7-10 or Compressed Gas (nitrogen) 10-30 or dimethyl ether 20-25 or fluoric ether 7-15
The preparation method of depilation spray of the present invention, comprises the steps: that A phase (oil phase) and B phase (water) are heated to respectively more than 80 ℃, then B phase (water) is slowly added in A phase (oil phase) to stirring, homogenizing; Add successively C phase (chemicals phase), D phase (medicine phase), E phase (plant extract phase/skin protection phase); Quantitative filling is to aluminium pot, and evacuation, is filled with F phase (propellant), sealing.
The present invention also relates to a kind of disposable depilation spray suit on the other hand, and it comprises the above-mentioned medical depilation spray of 25ml-100ml, disposable glove, a pasteurization towelette.
The invention still further relates to the application of above-mentioned medical depilation spray in operation preserved skin (depilation, sterilization).
The present invention can replace existing traditional preserved skin technology and product, it can be fast, effectively, safety, quickly patient is carried out to unconventional traditional preserved skin, sterilization, preserved skin be success once, greatly reduces the infection rate of preserved skin position and operative incision, has also reduced the risk of operation simultaneously.
The specific embodiment:
Formula: (%)
A phase (oil phase) B phase (water)
High viscosity white oil 2.0-5.0 carbamide 5.0-10.0
Silicone oil 1.0-4.0 sodium pyrosulfite 0.2-0.4
Emulsifying agent 4.0-8.0 60% potassium hydroxide solution 3.0-7.0
16-18 alcohol 4.0-8.0 carbomer Carbopol 934 0.1-0.3
Stearic acid 1.0-3.0 glycerol 3.0-7.0
Essence 0-0.4 propylene glycol 3.0-7.0
Methyl p-hydroxybenzoate 0.1-0.3 deionized water adds to 100
Ethyl hydroxybenzoate 0.5-1.0
C phase (chemical agent phase) D phase (biological agent phase)
Three hydration calcium mercaptoacetate 6.0-15.0 triclosan or quaternary ammonium salt 0.1-3
Calcium hydroxide 0.8-1.5 neutral red bisabolol 0.2-0.4
E phase (plant extract phase/skin protection phase)
Mentholum 0.1-0.3
Vitamin E 0.5-1.5
Aloe extraction solution 3.0-7.0
F phase (propellant)
Normal butane, iso-butane and/or n-propane 7-10 or Compressed Gas (nitrogen) 10-30 or dimethyl ether 20-25 or fluoric ether 7-15
Compound method: 1, A phase (oil phase) and B phase (water) are respectively heated to 85 ℃, then slowly adds B phase (water) in A phase (oil phase), stirring, homogenizing;
2, add successively C phase (chemicals phase), D phase (medicine phase), E phase (plant extract phase/skin protection phase);
3, quantitative filling is to aluminium pot, and evacuation, is filled with F phase (gas phase), sealing.
the unit of each composition is G, can be also KG, is the content of percentage ratio.Wherein A-F is mutually
the order adding successively and purpose classification
Research group use Dispoable medical depilation spray preserved skin, routine shave mao preserved skin respectively (every group of 50 rats) 100 rats have been carried out to the experiment of animal preserved skin pain stimulation, preserved skin depilation experiment, preserved skin depilation hair growth experiment after ten days, preserved skin depilation position is back, Dispoable medical depilation spray using dosage is 8g, preserved skin area 5cm
2, be 8 minutes action time, experimental studies have found that:
Research group use Dispoable medical depilation spray preserved skin, routine shave mao preserved skin respectively (every group of 50 rats) 100 rats have been carried out to the experiment of animal preserved skin pain stimulation, preserved skin depilation experiment, preserved skin depilation hair growth experiment after ten days, preserved skin depilation position is back, Dispoable medical depilation spray using dosage is 8g, preserved skin area 5cm
2, be 8 minutes action time, experimental studies have found that:
Adopt medical depilation spray of the present invention, preserved skin position is without pain, and preserved skin position is thoroughly clean, does not stay dead angle, do not seal hair follicle, only rupture hair, depilation after hair follicle root of hair is had no adverse effects, depilation group grows new hair again after ten days, physiological function is normal.
Should be understood that; the above-mentioned specific embodiment is only exemplary explanation, rather than limitation of the present invention, for those of ordinary skills; can be improved according to the above description or convert, and all these improvement and conversion all should belong to the protection domain of claims of the present invention.
Claims (5)
1. medical depilation spray, is characterized in that the composition that contains following weight proportioning %:
Formula:
C phase D phase
Three hydration calcium mercaptoacetate 6.0-15.0 triclosan or quaternary ammonium salt 0.1-3
Calcium hydroxide 0.8-1.5 neutral red bisabolol 0.2-0.4
F phase
Normal butane, iso-butane and/or n-propane 7-10 or compressed nitrogen 10-30 or dimethyl ether 20-25 or fluoric ether 7-15.
2. medical depilation spray, is characterized in that the composition that contains following weight proportioning %:
Formula:
C phase D phase
Three hydration calcium mercaptoacetate 6.0-15.0 triclosan or quaternary ammonium salt 0.1-3
Calcium hydroxide 0.8-1.5 neutral red bisabolol 0.2-0.4
F phase
Normal butane, iso-butane and/or n-propane 7-10 or compressed nitrogen 10-30 or dimethyl ether 20-25 or fluoric ether 7-15.
3. medical depilation spray according to claim 1 and 2, is characterized in that described emulsifying agent is A25.
4. Dispoable medical depilation spray is set with, and it comprises the medical depilation spray described in 25ml-100ml claim 1-3 any one, disposable glove, a pasteurization towelette.
5. the preparation method of the depilation spray described in claim 1 or 2, comprises the steps: that A phase and B are heated to respectively more than 80 ℃ mutually, then B is slowly added mutually A mutually in, stir, homogenizing; Add successively C phase, D phase, E phase; Quantitative filling is to aluminium pot, and evacuation, is filled with F phase, sealing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210076954.1A CN102600049B (en) | 2012-03-22 | 2012-03-22 | Medical unhairing spray and purpose of medical unhairing spray |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210076954.1A CN102600049B (en) | 2012-03-22 | 2012-03-22 | Medical unhairing spray and purpose of medical unhairing spray |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102600049A CN102600049A (en) | 2012-07-25 |
| CN102600049B true CN102600049B (en) | 2014-03-19 |
Family
ID=46518080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210076954.1A Expired - Fee Related CN102600049B (en) | 2012-03-22 | 2012-03-22 | Medical unhairing spray and purpose of medical unhairing spray |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600049B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988236B (en) * | 2012-11-30 | 2015-06-24 | 哈尔滨医科大学 | Skin preparation solution used when head skin is prepared before neurosurgery operation and preparation method and application thereof |
| RU2657520C2 (en) * | 2016-11-07 | 2018-06-14 | Павел Александрович Громенко | Cosmetic composition for removal of undesirable hair on the body of a person |
| CN114767563A (en) * | 2022-05-09 | 2022-07-22 | 广州睿新生物科技有限公司 | Mild and mild quick-acting depilatory composition and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2415135A (en) * | 2004-06-15 | 2005-12-21 | Reckitt Benckiser | Improvements in and relating to depilatory compositions |
| CN101756816A (en) * | 2008-11-12 | 2010-06-30 | 曲磊 | Calcium thioglycollate hair removal foam |
| GB0900582D0 (en) * | 2009-01-15 | 2009-02-11 | Reckitt & Colman Overseas | Tropical composition |
| WO2011103233A1 (en) * | 2010-02-17 | 2011-08-25 | The Procter & Gamble Company | Effective depilatory article |
| CN102058488A (en) * | 2010-11-11 | 2011-05-18 | 广州市好迪化妆品有限公司 | Low-pressure type propellant and application thereof |
| CN102166169A (en) * | 2010-11-29 | 2011-08-31 | 吴克 | Follicle shrinking and unhairing cream |
-
2012
- 2012-03-22 CN CN201210076954.1A patent/CN102600049B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102600049A (en) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4418976B2 (en) | Antiseptic disinfectant and cosmetic composition | |
| CN104188849B (en) | A kind of gentle effective anti-acne control fluid composition and preparation method thereof | |
| CN104490630A (en) | No-washing foam hand disinfection solution and preparation method thereof | |
| CN104105472A (en) | Topical oil composition for the treatment of fungal infections | |
| CN102600049B (en) | Medical unhairing spray and purpose of medical unhairing spray | |
| WO2014131191A1 (en) | A composition containing honokiol and/or magnolol and uses thereof | |
| CN102920612A (en) | Broad-spectrum antibacterial cosmetic antiseptic and application thereof | |
| US20180353448A1 (en) | Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne | |
| EP3359124A1 (en) | Composition comprising niacinamide and picolinamide | |
| CN103976914A (en) | China creeper root extracting solution as well as preparation method and application thereof | |
| CN111228201A (en) | Preparation method of hand-washing-free gel | |
| CN108210393A (en) | A kind of anti-bacteria wet keeping de-cutin shower dew and preparation method thereof | |
| CN104434609B (en) | A kind of compound Chinese medicine extract with acne-removal function and its application in cosmetics | |
| JP2008510805A (en) | Cosmetic composition comprising certain cyclohexane mono-, di- or triol, or cyclohexylmethane, ethane or propanol | |
| CN109276485B (en) | Acne removing patch and preparation method thereof | |
| EP3166582B1 (en) | Use of spiculisporic acid and/or a salt thereof as antidandruff agent, and cosmetic treatment process employing same | |
| CN105899221A (en) | Dermatological composition based on algae and olive leaf extracts | |
| Miller et al. | Local treatment of tinea capitis | |
| CN108451799A (en) | A kind of hand cleanser and preparation method thereof | |
| JP4113614B2 (en) | Gel-like product manufacturing method | |
| WO2014190227A1 (en) | Wound care product with egg shell membrane | |
| JP5138299B2 (en) | Dermal preparation | |
| WO2008091161A1 (en) | Cosmetic composition containing spermine and emu oil | |
| CN104083406B (en) | A kind of compound disinfectant and preparation method thereof | |
| BRPI1101172A2 (en) | deodorant and antiperspirant composition, process for producing deodorant and antiperspirant composition and method for the prevention and / or reduction of perspiration odors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160408 Address after: 211505 D7 building, Zhongshan Science Park, Liuhe District, Jiangsu, Nanjing Patentee after: NANJING YAFANG PHARMACEUTICAL Co.,Ltd. Address before: 210061, No. 3-3, salt transportation road, Yi Town, Guanyun County, Jiangsu Patentee before: Xu Kezhi |
|
| DD01 | Delivery of document by public notice |
Addressee: Xu Kezhi Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Xu Kezhi Document name: Notice of Termination of Patent Rights |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140319 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |